| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.24 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.06 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.13 | 0.7 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |